FCH
MD icon

Freestone Capital Holdings’s Pediatrix Medical MD Stock Holding History

Freestone Capital Holdings’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-35,097
Closed -$1.95M – 359
2018
Q1 		$1.95M Buy
35,097
+27,469
+360% +$1.51M 0.11% 156
2017
Q4 		$408K Buy
+7,628
New +$360K 0.03% 283

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Freestone Capital Holdings's MD Position: Q2 2018 in Review

Freestone Capital Holdings sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 35,097 shares — an estimated $1.95M sold.

Freestone Capital Holdings first reported a position in MD in Q4 2017 and held it in 2 quarters. The position peaked at $1.95M in Q1 2018. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • Freestone Capital Holdings reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
  • Freestone Capital Holdings sold 35,097 Pediatrix Medical shares in Q2 2018, an estimated $1.95M.
  • Freestone Capital Holdings first reported a position in Pediatrix Medical in Q4 2017 and held it in 2 quarters.
  • Freestone Capital Holdings's Pediatrix Medical position peaked at $1.95M in Q1 2018.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on Freestone Capital Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.